Experiences with long acting injectable ART: A qualitative study among PLHIV participating in a Phase II study of cabotegravir + rilpivirine (LATTE-2) in the United States and Spain

  1. Kerrigan, D.
  2. Mantsios, A.
  3. Gorgolas, M.
  4. Montes, M.-L.
  5. Pulido, F.
  6. Brinson, C.
  7. deVente, J.
  8. Richmond, G.J.
  9. Beckham, S.W.
  10. Hammond, P.
  11. Margolis, D.
  12. Murray, M.
Journal:
PLoS ONE

ISSN: 1932-6203

Year of publication: 2018

Volume: 13

Issue: 1

Type: Article

DOI: 10.1371/JOURNAL.PONE.0190487 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus